Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA006507 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA006507, RRID:AB_1079578
- Product name
- Anti-PCK1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human PCK1, Gene description: phosphoenolpyruvate carboxykinase 1 (soluble), Alternative Gene Names: PEPCK-C, Validated applications: IHC, WB, Uniprot ID: P35558, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Intestinal stem cell-derived enteroids from morbidly obese patients preserve obesity-related phenotypes: Elevated glucose absorption and gluconeogenesis
In Vivo Characterization of the Toxicological Properties of DPhP, One of the Main Degradation Products of Aryl Phosphate Esters
Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma
Hasan N, Johnson K, Yin J, Baetz N, Fayad L, Sherman V, Blutt S, Estes M, Kumbhari V, Zachos N, Kovbasnjuk O
Molecular Metabolism 2021;44
Molecular Metabolism 2021;44
In Vivo Characterization of the Toxicological Properties of DPhP, One of the Main Degradation Products of Aryl Phosphate Esters
Selmi-Ruby S, Marín-Sáez J, Fildier A, Buleté A, Abdallah M, Garcia J, Deverchère J, Spinner L, Giroud B, Ibanez S, Granjon T, Bardel C, Puisieux A, Fervers B, Vulliet E, Payen L, Vigneron A
Environmental Health Perspectives 2020;128(12)
Environmental Health Perspectives 2020;128(12)
Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma
Gutteridge R, Singh C, Ndiaye M, Ahmad N
Cancer Letters 2017;394
Cancer Letters 2017;394
No comments: Submit comment
Enhanced validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Recombinant expression validation
- Main image
- Experimental details
- Western blot analysis in control (vector only transfected HEK293T lysate) and PCK1 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells, LY419231).
- Sample type
- Human
- Protocol
- Protocol
